We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Pharma Group Takes Swipe At EU Antitrust Probe

Law360 (May 14, 2009, 12:00 AM EDT) -- An official from the European Federation of Pharmaceutical Industries and Associations has reportedly taken aim at a preliminary inquiry from the European Commission's Directorate General for Competition into whether Europe's pharmaceutical companies are blocking generic competition, arguing that the inquiry's findings could weaken patent enforcement rules and hinder innovation.

Thomas Cueni, head of Swiss pharmaceutical research association Interpharma and leader of the EFPIA's task force responding to the November inquiry, said in a speech during the federation’s annual meeting Thursday that the inquiry misplaced blame for...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.